Circulating cell-free DNA-based multi-cancer early detection.

Zhang, Kai; Fu, Ruiqing; Liu, Rui; Su, Zhixi

Zhang, Kai; Fu, Ruiqing; Liu, Rui; Su, Zhixi.

Afiliação

Zhang K; Department of Cancer Prevention, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South Panjiayuan Lane, Chaoyang District, Beijing 100021, China.
Fu R; Singlera Genomics Ltd, Shanghai 201203, China.
Liu R; Singlera Genomics Ltd, Shanghai 201203, China.
Su Z; Singlera Genomics Ltd, Shanghai 201203, China. Electronic address: zhixi.su@singleragenomics.com.

Trends Cancer ; 10(2): 161-174, 2024 02.

Article em En | MEDLINE | ID: mdl-37709615

Assuntos

Ácidos Nucleicos Livres; Neoplasias; Humanos; Detecção Precoce de Câncer; Ácidos Nucleicos Livres/genética; Neoplasias/diagnóstico; Neoplasias/genética

Palavras-chave

DNA methylation; cancer screening; circulating cell-free DNA (cfDNA); fragmentomics; multi-cancer early detection (MCED); tissue of origin (TOO)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácidos Nucleicos Livres / Neoplasias Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google